Stay updated on IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.

Latest updates to the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check26 days agoChange DetectedA site notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides a link to updates and FAQs.SummaryDifference0.8%

- Check33 days agoChange DetectedThe site revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history adds Revision: v3.7.0 and removes the previous v3.6.6, signaling that the study record has been updated to a newer version.SummaryDifference0.1%

- Check82 days agoChange DetectedRecord History now displays the latest release revision as v3.6.6, replacing the previous v3.6.5. This reflects a backend update to the page metadata rather than any change to trial details.SummaryDifference0.1%

Stay in the know with updates to IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.